Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study

Objective: To provide an understanding of the incidence of anaplastic thyroid cancer within the United States. Methods: Patients in the Surveillance, Epidemiology, and End Results (SEER) database were included from 1973 to 2014 based on a diagnosis of anaplastic thyroid cancer using ICD O-3 codes. P...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tyler A. Janz, David M. Neskey, Shaun A. Nguyen, Eric J. Lentsch
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2019
Materias:
Acceso en línea:https://doaj.org/article/b554ae9fe19242349b19d56ef1efd0ab
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b554ae9fe19242349b19d56ef1efd0ab
record_format dspace
spelling oai:doaj.org-article:b554ae9fe19242349b19d56ef1efd0ab2021-12-02T12:53:46ZIs the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study2095-881110.1016/j.wjorl.2018.05.006https://doaj.org/article/b554ae9fe19242349b19d56ef1efd0ab2019-03-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095881118300374https://doaj.org/toc/2095-8811Objective: To provide an understanding of the incidence of anaplastic thyroid cancer within the United States. Methods: Patients in the Surveillance, Epidemiology, and End Results (SEER) database were included from 1973 to 2014 based on a diagnosis of anaplastic thyroid cancer using ICD O-3 codes. Patients were categorized into cohorts based on their year of diagnosis. Results: 1527 patients were diagnosed with anaplastic thyroid cancer within the SEER 18 registries. The age-adjusted incidence rate was 0.2 per 1,000,000 people (95% CI: 0.0–0.5) in 1973 and was 1.2 per 1,000,000 people (95% CI: 0.8–1.6) in 2014 (average annual percent change: 3.0% [95% CI: 2.2%–3.7%]). Patients tended to be of older age (mean age: 70.5 [range 15.0–102.0]), of female sex (62.8%), and Caucasian (81.1%). Finally, survival over time remained the same, as median disease specific survival months was 4.00 (95% CI: 2.26–5.74) from 1995 to 1999 and 4.00 (95% CI: 3.26–4.74) from 2010 to 2014. Conclusions: The incidence rate of anaplastic thyroid cancer has increased from 1973 to 2014. Interestingly, median survival in months did not greatly change overtime. Based on this increasing incidence, physicians must act appropriately to identify patients with anaplastic thyroid cancer as it possesses a high morbidity and mortality. Level of evidence: 4. Keywords: Anaplastic thyroid cancer, Thyroid cancer, Head and neck, Head and neck endocrine surgery, Head and neck oncologyTyler A. JanzDavid M. NeskeyShaun A. NguyenEric J. LentschKeAi Communications Co., Ltd.articleOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 5, Iss 1, Pp 34-40 (2019)
institution DOAJ
collection DOAJ
language EN
topic Otorhinolaryngology
RF1-547
Surgery
RD1-811
spellingShingle Otorhinolaryngology
RF1-547
Surgery
RD1-811
Tyler A. Janz
David M. Neskey
Shaun A. Nguyen
Eric J. Lentsch
Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study
description Objective: To provide an understanding of the incidence of anaplastic thyroid cancer within the United States. Methods: Patients in the Surveillance, Epidemiology, and End Results (SEER) database were included from 1973 to 2014 based on a diagnosis of anaplastic thyroid cancer using ICD O-3 codes. Patients were categorized into cohorts based on their year of diagnosis. Results: 1527 patients were diagnosed with anaplastic thyroid cancer within the SEER 18 registries. The age-adjusted incidence rate was 0.2 per 1,000,000 people (95% CI: 0.0–0.5) in 1973 and was 1.2 per 1,000,000 people (95% CI: 0.8–1.6) in 2014 (average annual percent change: 3.0% [95% CI: 2.2%–3.7%]). Patients tended to be of older age (mean age: 70.5 [range 15.0–102.0]), of female sex (62.8%), and Caucasian (81.1%). Finally, survival over time remained the same, as median disease specific survival months was 4.00 (95% CI: 2.26–5.74) from 1995 to 1999 and 4.00 (95% CI: 3.26–4.74) from 2010 to 2014. Conclusions: The incidence rate of anaplastic thyroid cancer has increased from 1973 to 2014. Interestingly, median survival in months did not greatly change overtime. Based on this increasing incidence, physicians must act appropriately to identify patients with anaplastic thyroid cancer as it possesses a high morbidity and mortality. Level of evidence: 4. Keywords: Anaplastic thyroid cancer, Thyroid cancer, Head and neck, Head and neck endocrine surgery, Head and neck oncology
format article
author Tyler A. Janz
David M. Neskey
Shaun A. Nguyen
Eric J. Lentsch
author_facet Tyler A. Janz
David M. Neskey
Shaun A. Nguyen
Eric J. Lentsch
author_sort Tyler A. Janz
title Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study
title_short Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study
title_full Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study
title_fullStr Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study
title_full_unstemmed Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study
title_sort is the incidence of anaplastic thyroid cancer increasing: a population based epidemiology study
publisher KeAi Communications Co., Ltd.
publishDate 2019
url https://doaj.org/article/b554ae9fe19242349b19d56ef1efd0ab
work_keys_str_mv AT tylerajanz istheincidenceofanaplasticthyroidcancerincreasingapopulationbasedepidemiologystudy
AT davidmneskey istheincidenceofanaplasticthyroidcancerincreasingapopulationbasedepidemiologystudy
AT shaunanguyen istheincidenceofanaplasticthyroidcancerincreasingapopulationbasedepidemiologystudy
AT ericjlentsch istheincidenceofanaplasticthyroidcancerincreasingapopulationbasedepidemiologystudy
_version_ 1718393589329821696